

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.27621987 |
| 2 | regulation of ARF GTPase activity (GO:0032312) | 4.99699360 |
| 3 | epithelial structure maintenance (GO:0010669) | 4.17215638 |
| 4 | histone H3-K36 demethylation (GO:0070544) | 3.96529720 |
| 5 | mannose metabolic process (GO:0006013) | 3.86012484 |
| 6 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.83336250 |
| 7 | histone H3-K4 trimethylation (GO:0080182) | 3.77880514 |
| 8 | regulation of G0 to G1 transition (GO:0070316) | 3.75843256 |
| 9 | cellular response to epidermal growth factor stimulus (GO:0071364) | 3.69974397 |
| 10 | histone H3-K4 methylation (GO:0051568) | 3.60505800 |
| 11 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.58926615 |
| 12 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.52597358 |
| 13 | negative regulation of myotube differentiation (GO:0010832) | 3.52397501 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.46310019 |
| 15 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.41086463 |
| 16 | establishment of protein localization to Golgi (GO:0072600) | 3.39993866 |
| 17 | response to muramyl dipeptide (GO:0032495) | 3.39154319 |
| 18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.34061026 |
| 19 | response to epidermal growth factor (GO:0070849) | 3.33778783 |
| 20 | positive regulation of granulocyte differentiation (GO:0030854) | 3.26760860 |
| 21 | protein targeting to Golgi (GO:0000042) | 3.22422515 |
| 22 | corticosteroid receptor signaling pathway (GO:0031958) | 3.19031123 |
| 23 | histone lysine methylation (GO:0034968) | 3.18802066 |
| 24 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.17077555 |
| 25 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.14611903 |
| 26 | cellular extravasation (GO:0045123) | 3.13506387 |
| 27 | histone lysine demethylation (GO:0070076) | 3.07589764 |
| 28 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.04831601 |
| 29 | histone demethylation (GO:0016577) | 3.02196049 |
| 30 | interkinetic nuclear migration (GO:0022027) | 3.02000202 |
| 31 | striated muscle atrophy (GO:0014891) | 2.99364096 |
| 32 | response to vitamin A (GO:0033189) | 2.98578442 |
| 33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.94910083 |
| 34 | TOR signaling (GO:0031929) | 2.94742804 |
| 35 | response to misfolded protein (GO:0051788) | 2.93954796 |
| 36 | regulation of histone H3-K27 methylation (GO:0061085) | 2.92958962 |
| 37 | regulation of gamma-delta T cell activation (GO:0046643) | 2.89043592 |
| 38 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.88868758 |
| 39 | skeletal muscle adaptation (GO:0043501) | 2.85991906 |
| 40 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.83875890 |
| 41 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.83875890 |
| 42 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.83875890 |
| 43 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.83449710 |
| 44 | cellular response to ethanol (GO:0071361) | 2.81495509 |
| 45 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.80757918 |
| 46 | detection of molecule of bacterial origin (GO:0032490) | 2.80575968 |
| 47 | thymic T cell selection (GO:0045061) | 2.79061837 |
| 48 | histone H3-K9 modification (GO:0061647) | 2.77023621 |
| 49 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.75115408 |
| 50 | definitive hemopoiesis (GO:0060216) | 2.72737686 |
| 51 | phospholipid scrambling (GO:0017121) | 2.71723732 |
| 52 | histone H3-K9 demethylation (GO:0033169) | 2.70437565 |
| 53 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.69934433 |
| 54 | O-glycan processing (GO:0016266) | 2.67032922 |
| 55 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.66904855 |
| 56 | peptidyl-lysine trimethylation (GO:0018023) | 2.66679021 |
| 57 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.63370460 |
| 58 | atrioventricular valve morphogenesis (GO:0003181) | 2.59283514 |
| 59 | positive regulation of histone deacetylation (GO:0031065) | 2.58541911 |
| 60 | protein localization to Golgi apparatus (GO:0034067) | 2.56945880 |
| 61 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.55121479 |
| 62 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.53823863 |
| 63 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.53153595 |
| 64 | regulation of ARF protein signal transduction (GO:0032012) | 2.52660707 |
| 65 | muscle atrophy (GO:0014889) | 2.52472060 |
| 66 | regulation of granulocyte differentiation (GO:0030852) | 2.51639275 |
| 67 | regulation of necroptotic process (GO:0060544) | 2.51625226 |
| 68 | T cell selection (GO:0045058) | 2.50992960 |
| 69 | receptor catabolic process (GO:0032801) | 2.50688231 |
| 70 | negative regulation of fatty acid transport (GO:2000192) | 2.50452197 |
| 71 | neural tube development (GO:0021915) | 2.48584630 |
| 72 | protein demethylation (GO:0006482) | 2.47257077 |
| 73 | protein dealkylation (GO:0008214) | 2.47257077 |
| 74 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.46130910 |
| 75 | venous blood vessel morphogenesis (GO:0048845) | 2.45462908 |
| 76 | negative T cell selection (GO:0043383) | 2.43243826 |
| 77 | positive regulation of Rap GTPase activity (GO:0032854) | 2.42621312 |
| 78 | negative thymic T cell selection (GO:0045060) | 2.42128141 |
| 79 | phospholipid translocation (GO:0045332) | 2.42035520 |
| 80 | lipid translocation (GO:0034204) | 2.42035520 |
| 81 | focal adhesion assembly (GO:0048041) | 2.41701657 |
| 82 | cell-substrate adherens junction assembly (GO:0007045) | 2.41701657 |
| 83 | peptidyl-lysine methylation (GO:0018022) | 2.41092808 |
| 84 | regulation of RNA export from nucleus (GO:0046831) | 2.38840973 |
| 85 | positive regulation of protein kinase C signaling (GO:0090037) | 2.38163495 |
| 86 | positive thymic T cell selection (GO:0045059) | 2.37998672 |
| 87 | activation of Rac GTPase activity (GO:0032863) | 2.37553001 |
| 88 | histone methylation (GO:0016571) | 2.37547861 |
| 89 | apoptotic process involved in morphogenesis (GO:0060561) | 2.37170173 |
| 90 | response to laminar fluid shear stress (GO:0034616) | 2.34496894 |
| 91 | positive T cell selection (GO:0043368) | 2.34173379 |
| 92 | positive regulation of protein deacetylation (GO:0090312) | 2.33540514 |
| 93 | N-terminal protein amino acid acetylation (GO:0006474) | 2.32044963 |
| 94 | histone H3-K9 methylation (GO:0051567) | 2.31264636 |
| 95 | negative regulation of digestive system process (GO:0060457) | 2.31082400 |
| 96 | response to peptidoglycan (GO:0032494) | 2.29953705 |
| 97 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.28006919 |
| 98 | positive regulation by host of viral transcription (GO:0043923) | 2.27684965 |
| 99 | macrophage activation involved in immune response (GO:0002281) | 2.26945101 |
| 100 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.25356353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.18626070 |
| 2 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.94821041 |
| 3 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.92417426 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.91824929 |
| 5 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.80704027 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 2.79602699 |
| 7 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.72297485 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.66020443 |
| 9 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.48307312 |
| 10 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.43805558 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.37014727 |
| 12 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.31259118 |
| 13 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.28397331 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.19082516 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.16484013 |
| 16 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.10628309 |
| 17 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.09711335 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92549285 |
| 19 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.91657604 |
| 20 | KDM2B_26808549_Chip-Seq_K562_Human | 1.90395338 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.89832451 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89755347 |
| 23 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.87444988 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 1.86536182 |
| 25 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.84418850 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83981200 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.79532967 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.77057110 |
| 29 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.76235405 |
| 30 | GATA1_19941826_ChIP-Seq_K562_Human | 1.75097782 |
| 31 | MAF_26560356_Chip-Seq_TH2_Human | 1.73012854 |
| 32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.71028048 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.70317799 |
| 34 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.68638667 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64142949 |
| 36 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.62350944 |
| 37 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.59975740 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.58179752 |
| 39 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.56649224 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.55749299 |
| 41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.53539012 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52741339 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51738350 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.51320676 |
| 45 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.49172520 |
| 46 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.47709661 |
| 47 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.44647826 |
| 48 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.42703855 |
| 49 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.42373851 |
| 50 | P68_20966046_ChIP-Seq_HELA_Human | 1.40463785 |
| 51 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.37121148 |
| 52 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34881188 |
| 53 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.34636395 |
| 54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33011878 |
| 55 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.32885315 |
| 56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32659771 |
| 57 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.32518922 |
| 58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29833578 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.27876322 |
| 60 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.27354980 |
| 61 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26468870 |
| 62 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.26253662 |
| 63 | GATA2_19941826_ChIP-Seq_K562_Human | 1.25882263 |
| 64 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.25440474 |
| 65 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25061251 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23618986 |
| 67 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22230917 |
| 68 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.21939748 |
| 69 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21114225 |
| 70 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.19924479 |
| 71 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19480748 |
| 72 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.18555119 |
| 73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.18029579 |
| 74 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.17935474 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.17871380 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16848495 |
| 77 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.15841980 |
| 78 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.15713282 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14912978 |
| 80 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13720124 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13136781 |
| 82 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.11542990 |
| 83 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.09806531 |
| 84 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.06857353 |
| 85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04242254 |
| 86 | MYB_26560356_Chip-Seq_TH1_Human | 1.03542903 |
| 87 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02816644 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01810546 |
| 89 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01305477 |
| 90 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.01249882 |
| 91 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.98616981 |
| 92 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98087332 |
| 93 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.97390297 |
| 94 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97148248 |
| 95 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96949867 |
| 96 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.95551442 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94867493 |
| 98 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94269971 |
| 99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93741999 |
| 100 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.92219781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001348_abnormal_lacrimal_gland | 3.98735812 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.44394530 |
| 3 | MP0005076_abnormal_cell_differentiation | 3.25469423 |
| 4 | MP0005083_abnormal_biliary_tract | 3.15019402 |
| 5 | MP0008004_abnormal_stomach_pH | 2.59781772 |
| 6 | MP0003763_abnormal_thymus_physiology | 2.55189186 |
| 7 | MP0000465_gastrointestinal_hemorrhage | 2.54041869 |
| 8 | MP0003091_abnormal_cell_migration | 2.50874787 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.50719319 |
| 10 | MP0003436_decreased_susceptibility_to | 2.42596400 |
| 11 | MP0008057_abnormal_DNA_replication | 2.36538046 |
| 12 | MP0003866_abnormal_defecation | 2.34950109 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.19303012 |
| 14 | MP0003279_aneurysm | 2.19248661 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.17223332 |
| 16 | MP0003045_fibrosis | 2.14004539 |
| 17 | MP0004043_abnormal_pH_regulation | 1.97079766 |
| 18 | MP0005058_abnormal_lysosome_morphology | 1.82094954 |
| 19 | MP0003303_peritoneal_inflammation | 1.80068753 |
| 20 | MP0002249_abnormal_larynx_morphology | 1.75979264 |
| 21 | MP0008438_abnormal_cutaneous_collagen | 1.75898554 |
| 22 | MP0009278_abnormal_bone_marrow | 1.75511467 |
| 23 | MP0005451_abnormal_body_composition | 1.73072124 |
| 24 | MP0003879_abnormal_hair_cell | 1.70510613 |
| 25 | MP0008961_abnormal_basal_metabolism | 1.64985609 |
| 26 | MP0005310_abnormal_salivary_gland | 1.59901519 |
| 27 | MP0004381_abnormal_hair_follicle | 1.59547764 |
| 28 | MP0004808_abnormal_hematopoietic_stem | 1.59101750 |
| 29 | MP0005409_darkened_coat_color | 1.58470661 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.57307734 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.57307734 |
| 32 | MP0000566_synostosis | 1.52207125 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.49106542 |
| 34 | MP0001664_abnormal_digestion | 1.49031584 |
| 35 | MP0005275_abnormal_skin_tensile | 1.44090164 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.38519399 |
| 37 | MP0001851_eye_inflammation | 1.33059348 |
| 38 | MP0001800_abnormal_humoral_immune | 1.24520761 |
| 39 | MP0009840_abnormal_foam_cell | 1.21858098 |
| 40 | MP0004233_abnormal_muscle_weight | 1.19098498 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.18698237 |
| 42 | MP0004130_abnormal_muscle_cell | 1.18181451 |
| 43 | MP0001663_abnormal_digestive_system | 1.18007837 |
| 44 | MP0003828_pulmonary_edema | 1.14106175 |
| 45 | MP0004947_skin_inflammation | 1.13721838 |
| 46 | MP0002060_abnormal_skin_morphology | 1.12828072 |
| 47 | MP0005377_hearing/vestibular/ear_phenot | 1.10944569 |
| 48 | MP0003878_abnormal_ear_physiology | 1.10944569 |
| 49 | MP0002398_abnormal_bone_marrow | 1.09908885 |
| 50 | MP0005220_abnormal_exocrine_pancreas | 1.06336458 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.06145017 |
| 52 | MP0000470_abnormal_stomach_morphology | 1.04844464 |
| 53 | MP0005381_digestive/alimentary_phenotyp | 1.04157787 |
| 54 | MP0001835_abnormal_antigen_presentation | 1.01339840 |
| 55 | MP0005621_abnormal_cell_physiology | 1.01266333 |
| 56 | MP0002089_abnormal_postnatal_growth/wei | 0.99364672 |
| 57 | MP0001958_emphysema | 0.99172926 |
| 58 | MP0002933_joint_inflammation | 0.96407756 |
| 59 | MP0002822_catalepsy | 0.96179792 |
| 60 | MP0008995_early_reproductive_senescence | 0.95958747 |
| 61 | MP0003329_amyloid_beta_deposits | 0.95094966 |
| 62 | MP0000538_abnormal_urinary_bladder | 0.93980598 |
| 63 | MP0002970_abnormal_white_adipose | 0.93322196 |
| 64 | MP0003646_muscle_fatigue | 0.93049159 |
| 65 | MP0002419_abnormal_innate_immunity | 0.92075528 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 0.92042788 |
| 67 | MP0002420_abnormal_adaptive_immunity | 0.90365453 |
| 68 | MP0001819_abnormal_immune_cell | 0.89992585 |
| 69 | MP0002452_abnormal_antigen_presenting | 0.89824217 |
| 70 | MP0002998_abnormal_bone_remodeling | 0.88560360 |
| 71 | MP0009115_abnormal_fat_cell | 0.87463933 |
| 72 | MP0001765_abnormal_ion_homeostasis | 0.86412974 |
| 73 | MP0002928_abnormal_bile_duct | 0.86384164 |
| 74 | MP0002722_abnormal_immune_system | 0.85822302 |
| 75 | MP0001661_extended_life_span | 0.85658055 |
| 76 | MP0000685_abnormal_immune_system | 0.85406121 |
| 77 | MP0003183_abnormal_peptide_metabolism | 0.85224192 |
| 78 | MP0000733_abnormal_muscle_development | 0.84150850 |
| 79 | MP0002168_other_aberrant_phenotype | 0.83843022 |
| 80 | MP0005025_abnormal_response_to | 0.83815737 |
| 81 | MP0000716_abnormal_immune_system | 0.83139068 |
| 82 | MP0002405_respiratory_system_inflammati | 0.82712730 |
| 83 | MP0002723_abnormal_immune_serum | 0.81193473 |
| 84 | MP0000747_muscle_weakness | 0.80886169 |
| 85 | MP0005174_abnormal_tail_pigmentation | 0.80279975 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.77936364 |
| 87 | MP0001299_abnormal_eye_distance/ | 0.77041800 |
| 88 | MP0002009_preneoplasia | 0.76227897 |
| 89 | MP0005387_immune_system_phenotype | 0.75359823 |
| 90 | MP0001790_abnormal_immune_system | 0.75359823 |
| 91 | MP0009931_abnormal_skin_appearance | 0.75305016 |
| 92 | MP0000371_diluted_coat_color | 0.74871629 |
| 93 | MP0003943_abnormal_hepatobiliary_system | 0.74246396 |
| 94 | MP0004264_abnormal_extraembryonic_tissu | 0.74239123 |
| 95 | MP0000759_abnormal_skeletal_muscle | 0.73568135 |
| 96 | MP0006138_congestive_heart_failure | 0.73130359 |
| 97 | MP0002108_abnormal_muscle_morphology | 0.71523356 |
| 98 | MP0004036_abnormal_muscle_relaxation | 0.71445630 |
| 99 | MP0000579_abnormal_nail_morphology | 0.70815529 |
| 100 | MP0005448_abnormal_energy_balance | 0.69714647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the fingertips (HP:0001211) | 4.58984436 |
| 2 | Broad face (HP:0000283) | 3.92517972 |
| 3 | Cerebral aneurysm (HP:0004944) | 3.51549693 |
| 4 | Thin bony cortex (HP:0002753) | 3.39145249 |
| 5 | Long eyelashes (HP:0000527) | 3.25438129 |
| 6 | Abnormality of the columella (HP:0009929) | 3.24813462 |
| 7 | Narrow palate (HP:0000189) | 2.87146438 |
| 8 | Genetic anticipation (HP:0003743) | 2.79967493 |
| 9 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.79668109 |
| 10 | Hemorrhage of the eye (HP:0011885) | 2.74813233 |
| 11 | Dysmetric saccades (HP:0000641) | 2.63976134 |
| 12 | Obstructive sleep apnea (HP:0002870) | 2.62854538 |
| 13 | Mask-like facies (HP:0000298) | 2.59785384 |
| 14 | Hyperacusis (HP:0010780) | 2.55475090 |
| 15 | Colitis (HP:0002583) | 2.50925740 |
| 16 | Prominent nose (HP:0000448) | 2.50651421 |
| 17 | Abnormal pancreas size (HP:0012094) | 2.45372568 |
| 18 | Hyperkalemia (HP:0002153) | 2.41845729 |
| 19 | Mitral valve prolapse (HP:0001634) | 2.37510446 |
| 20 | Sandal gap (HP:0001852) | 2.33379044 |
| 21 | Malnutrition (HP:0004395) | 2.31612670 |
| 22 | Heterotopia (HP:0002282) | 2.31331492 |
| 23 | Tibial bowing (HP:0002982) | 2.30601658 |
| 24 | Self-mutilation (HP:0000742) | 2.30558074 |
| 25 | Ulnar bowing (HP:0003031) | 2.29312415 |
| 26 | Lip pit (HP:0100267) | 2.28851066 |
| 27 | Dislocated radial head (HP:0003083) | 2.21108290 |
| 28 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.20624221 |
| 29 | Truncal obesity (HP:0001956) | 2.19986025 |
| 30 | Urethral obstruction (HP:0000796) | 2.17592637 |
| 31 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.17146279 |
| 32 | Vertebral arch anomaly (HP:0008438) | 2.14076485 |
| 33 | Clumsiness (HP:0002312) | 2.12721402 |
| 34 | Neonatal hypoglycemia (HP:0001998) | 2.11371354 |
| 35 | Spondylolisthesis (HP:0003302) | 2.10310381 |
| 36 | Abnormality of incisor morphology (HP:0011063) | 2.10171652 |
| 37 | Genu recurvatum (HP:0002816) | 2.10081535 |
| 38 | Short nail (HP:0001799) | 2.09567373 |
| 39 | Annular pancreas (HP:0001734) | 2.08724194 |
| 40 | Aortic aneurysm (HP:0004942) | 2.05567877 |
| 41 | Increased connective tissue (HP:0009025) | 2.03153175 |
| 42 | Aneurysm (HP:0002617) | 2.02452218 |
| 43 | Distal lower limb amyotrophy (HP:0008944) | 2.02187141 |
| 44 | Abnormality of the radial head (HP:0003995) | 2.02027713 |
| 45 | Sparse lateral eyebrow (HP:0005338) | 2.00761062 |
| 46 | Spinal muscular atrophy (HP:0007269) | 1.93364839 |
| 47 | Fragile skin (HP:0001030) | 1.93014880 |
| 48 | Duplicated collecting system (HP:0000081) | 1.90670361 |
| 49 | Onion bulb formation (HP:0003383) | 1.90070742 |
| 50 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.87618224 |
| 51 | Rectal prolapse (HP:0002035) | 1.86859797 |
| 52 | Chromsome breakage (HP:0040012) | 1.85858757 |
| 53 | Ectopic kidney (HP:0000086) | 1.85793617 |
| 54 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.85623824 |
| 55 | Abnormality of dentin (HP:0010299) | 1.83497647 |
| 56 | Disproportionate tall stature (HP:0001519) | 1.83489173 |
| 57 | Mild short stature (HP:0003502) | 1.83083519 |
| 58 | Laryngomalacia (HP:0001601) | 1.82767464 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 1.82355344 |
| 60 | Depressed nasal tip (HP:0000437) | 1.80188094 |
| 61 | Enlarged epiphyses (HP:0010580) | 1.79628308 |
| 62 | Joint laxity (HP:0001388) | 1.79105098 |
| 63 | Peritonitis (HP:0002586) | 1.78924648 |
| 64 | Abnormality of DNA repair (HP:0003254) | 1.78661939 |
| 65 | Inflammation of the large intestine (HP:0002037) | 1.76336547 |
| 66 | Premature skin wrinkling (HP:0100678) | 1.76136756 |
| 67 | Flat occiput (HP:0005469) | 1.75830086 |
| 68 | Pili torti (HP:0003777) | 1.73784877 |
| 69 | Distal upper limb amyotrophy (HP:0007149) | 1.72877035 |
| 70 | Upper limb amyotrophy (HP:0009129) | 1.72877035 |
| 71 | Abnormality of the nasal septum (HP:0000419) | 1.72544697 |
| 72 | Ankyloglossia (HP:0010296) | 1.72442220 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 1.72096101 |
| 74 | Persistence of primary teeth (HP:0006335) | 1.70827246 |
| 75 | Aortic dissection (HP:0002647) | 1.70553414 |
| 76 | Abnormality of the renal collecting system (HP:0004742) | 1.69655268 |
| 77 | Abnormality of the thoracic spine (HP:0100711) | 1.68963037 |
| 78 | Bronchomalacia (HP:0002780) | 1.68186275 |
| 79 | Thoracic kyphosis (HP:0002942) | 1.67100189 |
| 80 | Spontaneous hematomas (HP:0007420) | 1.66984009 |
| 81 | Overgrowth (HP:0001548) | 1.66050746 |
| 82 | Acute myeloid leukemia (HP:0004808) | 1.65458370 |
| 83 | Smooth philtrum (HP:0000319) | 1.64567051 |
| 84 | Tracheomalacia (HP:0002779) | 1.63085260 |
| 85 | Atrophic scars (HP:0001075) | 1.63049511 |
| 86 | Germ cell neoplasia (HP:0100728) | 1.62192376 |
| 87 | Dilatation of the ascending aorta (HP:0005111) | 1.61976859 |
| 88 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.60784470 |
| 89 | Abnormality of chloride homeostasis (HP:0011422) | 1.59854862 |
| 90 | Thick eyebrow (HP:0000574) | 1.59627518 |
| 91 | Flat acetabular roof (HP:0003180) | 1.58680357 |
| 92 | Natal tooth (HP:0000695) | 1.56345612 |
| 93 | Prolonged bleeding time (HP:0003010) | 1.55403290 |
| 94 | Acute lymphatic leukemia (HP:0006721) | 1.52057129 |
| 95 | Abnormality of the aortic arch (HP:0012303) | 1.51880827 |
| 96 | Lower limb amyotrophy (HP:0007210) | 1.51859493 |
| 97 | Progressive cerebellar ataxia (HP:0002073) | 1.51666066 |
| 98 | Slow saccadic eye movements (HP:0000514) | 1.51277404 |
| 99 | Neonatal short-limb short stature (HP:0008921) | 1.51216595 |
| 100 | Eczematoid dermatitis (HP:0000976) | 1.51182632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 5.38723639 |
| 2 | TRIB3 | 3.52844875 |
| 3 | ICK | 3.23769096 |
| 4 | MST1R | 3.05876246 |
| 5 | WNK4 | 2.42667624 |
| 6 | BLK | 2.39581219 |
| 7 | CAMK1D | 2.29111207 |
| 8 | WNK1 | 2.28551596 |
| 9 | ERN1 | 1.90954224 |
| 10 | MARK2 | 1.90147121 |
| 11 | MAP2K3 | 1.89908299 |
| 12 | SIK1 | 1.84653499 |
| 13 | PRPF4B | 1.83449646 |
| 14 | MAP3K13 | 1.83422061 |
| 15 | EEF2K | 1.82039703 |
| 16 | CAMK1G | 1.73923653 |
| 17 | SIK2 | 1.71537627 |
| 18 | MTOR | 1.61639167 |
| 19 | NME1 | 1.61540358 |
| 20 | MAP3K7 | 1.52007738 |
| 21 | BRD4 | 1.46959401 |
| 22 | CDC42BPA | 1.44077420 |
| 23 | AKT3 | 1.31889130 |
| 24 | TRPM7 | 1.24855795 |
| 25 | MAP4K1 | 1.18364508 |
| 26 | ZAP70 | 1.05610568 |
| 27 | NEK2 | 1.04043345 |
| 28 | MELK | 0.97161034 |
| 29 | BTK | 0.96450619 |
| 30 | TTN | 0.94276136 |
| 31 | MAPK11 | 0.93993329 |
| 32 | MAPK15 | 0.93962160 |
| 33 | ACVR1B | 0.93590999 |
| 34 | FGFR4 | 0.90925906 |
| 35 | FRK | 0.90524593 |
| 36 | PKN2 | 0.90414432 |
| 37 | TNK2 | 0.87240650 |
| 38 | RIPK4 | 0.87221583 |
| 39 | CHUK | 0.87108156 |
| 40 | MAP3K10 | 0.86122628 |
| 41 | CAMKK1 | 0.83261687 |
| 42 | TAOK1 | 0.82759664 |
| 43 | MAPK12 | 0.82717888 |
| 44 | CAMK4 | 0.82694236 |
| 45 | PDGFRB | 0.81330293 |
| 46 | MAP3K6 | 0.80173490 |
| 47 | MARK3 | 0.78324466 |
| 48 | RIPK1 | 0.77969380 |
| 49 | RET | 0.77942266 |
| 50 | MET | 0.77165942 |
| 51 | PRKAA2 | 0.76753806 |
| 52 | MAP3K1 | 0.74315550 |
| 53 | SGK2 | 0.71848419 |
| 54 | RPS6KC1 | 0.71752264 |
| 55 | RPS6KL1 | 0.71752264 |
| 56 | TESK2 | 0.71290046 |
| 57 | MAP2K6 | 0.70724872 |
| 58 | RPS6KA6 | 0.70587561 |
| 59 | ERBB2 | 0.69423491 |
| 60 | SMG1 | 0.69333743 |
| 61 | FES | 0.69241745 |
| 62 | TYK2 | 0.68933733 |
| 63 | HIPK2 | 0.68238223 |
| 64 | PRKD2 | 0.66230893 |
| 65 | FGFR3 | 0.64072919 |
| 66 | PRKAA1 | 0.63250783 |
| 67 | HCK | 0.63171300 |
| 68 | SGK3 | 0.62441707 |
| 69 | KSR2 | 0.61869252 |
| 70 | IRAK4 | 0.61097139 |
| 71 | NLK | 0.60336097 |
| 72 | TYRO3 | 0.60198436 |
| 73 | MAP3K3 | 0.59854399 |
| 74 | MAP3K11 | 0.58935506 |
| 75 | SGK1 | 0.58644562 |
| 76 | GRK6 | 0.57873481 |
| 77 | RPS6KA2 | 0.57381254 |
| 78 | PDPK1 | 0.57144584 |
| 79 | EPHB1 | 0.56974733 |
| 80 | SGK223 | 0.54646376 |
| 81 | SGK494 | 0.54646376 |
| 82 | PIK3CG | 0.54005352 |
| 83 | CDK4 | 0.53910955 |
| 84 | IKBKE | 0.51651218 |
| 85 | PDGFRA | 0.51380761 |
| 86 | SYK | 0.49424601 |
| 87 | PDK1 | 0.48331571 |
| 88 | CSF1R | 0.47935214 |
| 89 | PRKCH | 0.47799608 |
| 90 | AKT1 | 0.47173831 |
| 91 | MAP3K14 | 0.46008875 |
| 92 | ITK | 0.45931120 |
| 93 | CSK | 0.45751405 |
| 94 | MAPK1 | 0.45084726 |
| 95 | MAPK7 | 0.42097108 |
| 96 | LCK | 0.41662300 |
| 97 | JAK1 | 0.41415796 |
| 98 | MAP2K2 | 0.41360397 |
| 99 | EPHA3 | 0.41212275 |
| 100 | IRAK2 | 0.40896350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Lysine degradation_Homo sapiens_hsa00310 | 2.30675919 |
| 2 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.87181840 |
| 3 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.74494772 |
| 4 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.73866611 |
| 5 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.73653235 |
| 6 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.59914666 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59343421 |
| 8 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.59089331 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.56925287 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.55244190 |
| 11 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.54749657 |
| 12 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.53404870 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.52795908 |
| 14 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.52220332 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.47524880 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44680079 |
| 17 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.40642185 |
| 18 | Platelet activation_Homo sapiens_hsa04611 | 1.36329871 |
| 19 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.35482331 |
| 20 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.32956765 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30475169 |
| 22 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.27819395 |
| 23 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.25567481 |
| 24 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24344033 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.23829916 |
| 26 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.21224156 |
| 27 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.13294590 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11493766 |
| 29 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.10657708 |
| 30 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.10446105 |
| 31 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.10272739 |
| 32 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09326326 |
| 33 | Endometrial cancer_Homo sapiens_hsa05213 | 1.09192355 |
| 34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08675630 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07213145 |
| 36 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.06330988 |
| 37 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.04965647 |
| 38 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04328392 |
| 39 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.03854486 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.03244580 |
| 41 | Prostate cancer_Homo sapiens_hsa05215 | 1.00682428 |
| 42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.99447385 |
| 43 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.99183215 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99145843 |
| 45 | Insulin resistance_Homo sapiens_hsa04931 | 0.98324890 |
| 46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.97464523 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.96072282 |
| 48 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.95529778 |
| 49 | Leishmaniasis_Homo sapiens_hsa05140 | 0.95192626 |
| 50 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.93502800 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.91904299 |
| 52 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.91350877 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91140585 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.90716233 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89785076 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.88688579 |
| 57 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.86907389 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85949912 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85509088 |
| 60 | Colorectal cancer_Homo sapiens_hsa05210 | 0.84445142 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84338134 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 0.83567703 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.82987105 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 0.82715153 |
| 65 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80059208 |
| 66 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.79623924 |
| 67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78067630 |
| 68 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77661916 |
| 69 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75642227 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.74557230 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.72853683 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71459283 |
| 73 | Tuberculosis_Homo sapiens_hsa05152 | 0.71245459 |
| 74 | Measles_Homo sapiens_hsa05162 | 0.68279514 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66976661 |
| 76 | Salivary secretion_Homo sapiens_hsa04970 | 0.65746587 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65119171 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65080153 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.64457519 |
| 80 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.62487184 |
| 81 | Malaria_Homo sapiens_hsa05144 | 0.62432532 |
| 82 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61276166 |
| 83 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60686241 |
| 84 | Long-term potentiation_Homo sapiens_hsa04720 | 0.60212018 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | 0.59015091 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58635275 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55794653 |
| 88 | Long-term depression_Homo sapiens_hsa04730 | 0.54703837 |
| 89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54491800 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53829882 |
| 91 | Adherens junction_Homo sapiens_hsa04520 | 0.53745267 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53739991 |
| 93 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.53702027 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53637075 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.53596036 |
| 96 | Taste transduction_Homo sapiens_hsa04742 | 0.52935820 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52646731 |
| 98 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.51573299 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51024450 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50921840 |

